Explanation:

Recently, India’s online pharmacy market saw two significant merger and acquisition deals — Reliance Retail picking up majority stake in Chennai-based e-pharmacy Netmeds, and PharmEasy moving to merge with smaller rival Medlife.

• The government had floated draft regulations for e-pharmacies but these guidelines never saw light of the day. Regulations for online pharmacy players have been in the works since 2016 but are yet to come out.
• Draft rules for e-pharmacies sought to define the online sale of medicines, what an e-prescription means and what type of licences online firms would need to get from regulators to operate.
• The draft had proposed to allow e-pharmacies to get a central licence to operate from the country’s apex drug regulator, which could be used to allow it to operate across the country.
• It also proposed to define e-pharmacies in a way that would allow them to distribute, sell and stock medicines.
• The proposed regulations prevent them from selling habit-forming drugs like cough syrups specified in Schedule X of the Indian drug regulations.

Hence both statements are correct.